NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
06/26/2026
Back to search
Official data from USPTO
HETLIOZ (TASIMELTEON) CAPSULES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
19
Latest update
06/26/2026
Trademark type
Combined
Nice classes
5
Filing date
04/01/2019
Registration date
04/28/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/26/2026
Last transaction
06/26/2026
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
04/15/2014
First use in commerce
04/15/2014
Drawing code
3
Owner type
03
Owner location
Washington, DC, US
Examiner
RADCLIFF, BRENT
Current location
Historical data usage
Mark description
The mark consists of the word "HETLIOZ" on a first line, and "(TASIMELTEON) CAPSULES" on a second line, with an arc of eleven solid circles of increasing size connecting the first and second lines of text.
Holders and representatives
Holders
Vanda Pharmaceuticals Inc.
Representatives
Jayme M. Torelli HOFFMAN WARNICK LLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparationscontaining tasimelteonfor use in the treatment of circadian rhythm diseases and disorders; and pharmaceutical preparationscontaining tasimelteonfor use in the treatment of non-24 hour sleep-wake disorder
Publications
History of USPTO decisions and trademark events.
19 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
06/26/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/26/2026
E815
TEAS SECTION 8 & 15 RECEIVED
03/27/2026
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
04/28/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
04/28/2020
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
03/25/2020
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
03/25/2020
IUCN
NOTICE OF ALLOWANCE CANCELLED
03/03/2020
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
03/03/2020
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
09/10/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/16/2019
PUBO
PUBLISHED FOR OPPOSITION
07/16/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/26/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/12/2019
DOCK
ASSIGNED TO EXAMINER
06/11/2019
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
04/20/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/19/2019
NWAP
NEW APPLICATION ENTERED
04/04/2019
Continuous trademark protection
Get notified about every new filing that threatens HETLIOZ (TASIMELTEON) CAPSULES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.